Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients
- PMID: 37984732
- DOI: 10.1016/j.metabol.2023.155739
Addressing uncertainty about the role of structured lifestyle modification for metabolic surgery patients
Abstract
There is good evidence that structured lifestyle modification programmes improve health in patients with metabolic and cardiovascular disorders, but there is no specific evidence that they improve outcomes in patients undergoing metabolic or obesity surgery. Despite expert consensus guidelines stating this fact, some healthcare systems still compel patients to participate in a structured lifestyle modification programme prior to metabolic or obesity surgery. There is a well-established need for individualised multidisciplinary dietetic and physical activity care for metabolic and obesity surgery patients, and the benefits of intentional weight loss prior to surgery are well proven, but these are distinct from potentially harmful requirements for patients to undertake compulsory structured lifestyle programmes of fixed duration, frequency and intensity, which may delay surgery and reinforce obesity stigma. A critical step in rejuvenating metabolic surgery is to reframe patient participation in structured lifestyle modification programmes as an opportunity for education and empowerment, not as an indicator of motivation or suitability for metabolic surgery. Large, well-designed and adequately powered clinical trials are needed to address uncertainties in the evidence base for these programmes. Given genuine equipoise, they will need to determine whether "surgery plus lifestyle" is superior to "surgery plus placebo". Moreover, they will need to determine the cost-effectiveness of these programmes and identify some of the factors giving rise to the substantial heterogeneity in responses to structured lifestyle modification.
Keywords: Metabolic surgery; Obesity; Structured lifestyle modification.
Copyright © 2023. Published by Elsevier Inc.
Conflict of interest statement
Declaration of competing interest EM has no conflicts of interest to declare. EM and FMF are both funded by a CÚRAM/Science Foundation Ireland Project Grant (ref 13/RC/2073-P2). FMF has served on Data Safety Monitoring Boards for the LEAP and LEGEND randomised controlled trials (run by the University of Michigan), and as a paid grant reviewer for the Danish Diabetes Academy.
Similar articles
-
Structured Lifestyle Modification Prior to Bariatric Surgery: How Much is Enough?Obes Surg. 2021 Oct;31(10):4585-4591. doi: 10.1007/s11695-021-05573-w. Epub 2021 Jul 23. Obes Surg. 2021. PMID: 34297255 Free PMC article. Review.
-
Structured lifestyle modification as an adjunct to obesity pharmacotherapy: there is much to learn.Int J Obes (Lond). 2024 Mar 8. doi: 10.1038/s41366-024-01499-2. Online ahead of print. Int J Obes (Lond). 2024. PMID: 38459258 Review.
-
Factors associated with weight loss and health gains in a structured lifestyle modification programme for adults with severe obesity: a prospective cohort study.Front Endocrinol (Lausanne). 2023 Oct 17;14:1257061. doi: 10.3389/fendo.2023.1257061. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37916153 Free PMC article.
-
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012513. doi: 10.1002/14651858.CD012513.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Mar 27;3:CD012513. doi: 10.1002/14651858.CD012513.pub3 PMID: 29388687 Free PMC article. Updated. Review.
-
CHALLENGES AND NEW DIRECTIONS IN OBESITY MANAGEMENT: LIFESTYLE MODIFICATION PROGRAMMES, PHARMACOTHERAPY AND BARIATRIC SURGERY.J Popul Ther Clin Pharmacol. 2019 May 23;26(2):e1-e4. doi: 10.15586/jptcp.v26i2.599. J Popul Ther Clin Pharmacol. 2019. PMID: 31577079
MeSH terms
LinkOut - more resources
Full Text Sources
Medical